Artisan近视型与Artisan环曲面有晶状体眼人工晶状体植入患者的长期内皮细胞丢失:5年与10年结果
这项前瞻性临床队列研究纳入1998年1月起在Maastricht大学眼科诊所接受Artisan近视型或Artisan环曲面虹膜固定型有晶状体眼人工晶状体(pIOL)植入的289例患者共507眼,评估术后长期内皮细胞密度变化。结果显示近视型与环曲面组均存在显著的线性慢性内皮细胞丢失,术后6个月至10年总丢失分别为16.6%和21.5%。前房深度较浅及pIOL边缘与内皮距离较小是内皮细胞丢失增加的风险因素。
要点
- 近视型pIOL组年内皮细胞密度下降48 cells/mm2,环曲面组为61 cells/mm2,两组均P < 0.001。
- 术后6个月至10年总内皮细胞丢失:近视型组16.6%,环曲面组21.5%。
- 术后10年内皮细胞密度下降≥25%者近视型组7.9%、环曲面组6.3%;内皮细胞密度<1500 cells/mm2者分别为3.9%和4.0%。
核心结论
- 近视型或环曲面虹膜固定型pIOL植入后存在显著的线性慢性内皮细胞丢失。
- 前房深度较浅和pIOL边缘至内皮距离较小是内皮细胞丢失的风险因素。
- 作者认为需要修改术前与年龄相关的内皮细胞密度阈值,以维持足以安全进行未来pIOL取出联合白内障手术的内皮细胞密度。
研究设计与样本
- 前瞻性临床队列研究。
- 共纳入289例患者的507眼,自1998年1月起在Maastricht大学眼科诊所接受Artisan近视型或Artisan环曲面虹膜固定型pIOL植入。
- 共植入381枚近视型pIOL和126枚环曲面pIOL;完成5年和10年随访的近视型pIOL眼分别为193眼和127眼,环曲面pIOL眼分别为40眼和20眼。
主要发现
- 慢性内皮细胞丢失从术后6个月计算至随访结束:近视型组年内皮细胞密度下降48 cells/mm2(标准误3.14,P < 0.001),环曲面组下降61 cells/mm2(标准误6.30,P < 0.001)。
- 术后6个月至10年总内皮细胞丢失:近视型组16.6%,环曲面组21.5%。
- 术后10年,内皮细胞密度下降≥25%者近视型组7.9%、环曲面组6.3%;内皮细胞密度<1500 cells/mm2者近视型组3.9%、环曲面组4.0%。
- pIOL取出率:近视型组6.0%,环曲面组4.8%。
- 内皮细胞丢失增加的风险因素为前房深度较浅(P ≤ 0.005)以及中央与周边pIOL边缘至内皮的距离较小(P ≤ 0.005)。
关键数值与推荐
- 主要结局指标为慢性内皮细胞丢失、内皮细胞密度下降≥25%的眼占比及内皮细胞密度<1500 cells/mm2的眼占比。
- 慢性内皮细胞丢失自术后6个月计算至随访结束。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To evaluate the long-term change in endothelial cell density (ECD) after the implantation of 2 types of rigid iris-fixated phakic intraocular lenses (pIOLs) for the treatment of myopia and astigmatism. DESIGN: Prospective, clinical cohort study. PARTICIPANTS: A total of 507 eyes of 289 patients receiving the Artisan Myopia or Artisan Toric (Ophtec B.V., Groningen, The Netherlands) iris-fixated pIOL for the treatment of myopia or astigmatism at the University Eye Clinic Maastricht as of January 1998. METHODS: A total of 381 myopic and 126 toric pIOLs were implanted. Five- and 10-year follow-ups were completed by 193 and 127 eyes implanted with the myopic pIOL and by 40 and 20 eyes implanted with the toric pIOL, respectively. MAIN OUTCOME MEASURES: Chronic endothelial cell (EC) loss, percentage of eyes with a decrease of ≥25% in ECD, and percentage of eyes with an ECD <1500 cells/mm2. RESULTS: Chronic EC loss was calculated from 6 months postoperatively to the end of follow-up and showed an annual ECD decline of 48 cells/mm2 (standard error, 3.14) and 61 cells/mm2 (standard error, 6.30) in the myopic (P < 0.001) and toric (P < 0.001) groups, respectively, resulting in a total EC loss of 16.6% and 21.5% from 6 months to 10 years postoperatively, respectively. Ten years after implantation, ECD had decreased by ≥25% in 7.9% and 6.3%, whereas ECD was <1500 cells/mm2 in 3.9% and 4.0% in the myopic and toric groups, respectively. Explantation of the pIOL occurred in 6.0% in the myopic group and 4.8% in the toric group. Risk factors for increased EC loss were a shallow anterior chamber depth (ACD) (P ≤ 0.005) and a smaller distance between the central and peripheral pIOL edge to the endothelium (P ≤ 0.005). CONCLUSIONS: A significant linear chronic EC loss was reported after implantation with myopic or toric iris-fixated pIOLs. A smaller ACD and smaller distance between pIOL edge and endothelium were risk factors for EC loss. Modification of preoperative age-related ECD thresholds is indicated to maintain an ECD that warrants safe future combined pIOL explantation and cataract surgery.
引用
- Jonker SMR, Berendschot TTJM, Ronden AE, et al. Long-Term Endothelial Cell Loss in Patients with Artisan Myopia and Artisan Toric Phakic Intraocular Lenses: 5- and 10-Year Results. Ophthalmology. 2017. PMID: 28935401. doi:10.1016/j.ophtha.2017.08.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。